Sagimet Biosciences (SGMT) Other financing activities (2022 - 2025)

Sagimet Biosciences' Other financing activities history runs 4 years deep, the most recent figure standing at $1000.0 for Q2 2025.

• In Q2 2025, Other financing activities fell 96.3% year-over-year to $1000.0; the TTM figure through Dec 2025 stood at $1000.0 (down 99.9% YoY), while the FY2024 annual figure was $1.0 million, down 70.3% from the prior year.
• Other financing activities was $1000.0 for Q2 2025 at Sagimet Biosciences, down from $27000.0 in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $1.0 million in Q1 2024 to a low of $1000.0 in Q2 2025.
• Historically, Other financing activities has averaged $357833.3 across 4 years, with a median of $95500.0 in 2022.
• Biggest YoY gain for Other financing activities was 648.53% in 2024; the steepest drop was 97.03% in 2024.
• A 4-year view of Other financing activities shows it stood at $55000.0 in 2022, then jumped by 1554.55% to $910000.0 in 2023, then slumped by 97.03% to $27000.0 in 2024, then slumped by 96.3% to $1000.0 in 2025.
• The last three Other financing activities figures came in at $1000.0 (Q2 2025), $27000.0 (Q2 2024), and $1.0 million (Q1 2024), per Business Quant data.